Sign In
Buy NARI
$79.97
+0 (+0%)
At Close: May 16, 2025
Inari Medical to Announce First Quarter 2024 Financial Results
04:05pm, Wednesday, 17'th Apr 2024
IRVINE, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering fr
Why You Should Retain Inari Medical (NARI) Stock for Now
12:06pm, Tuesday, 09'th Apr 2024
Inari Medical (NARI) continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.
Inari Medical (NARI) Up 4% Since Last Earnings Report: Can It Continue?
12:36pm, Friday, 29'th Mar 2024
Inari Medical (NARI) reported earnings 30 days ago. What's next for the stock?
Inari Medical's (NARI) ClotTriever Improves Patient Outcome
11:46am, Thursday, 14'th Mar 2024
Inari Medical (NARI) announces two-year interim results from the CLOUT registry, which shows a significant improvement in patient's post-thrombotic syndrome and lower rethrombosis-related events.
Reasons to Retain Inari Medical (NARI) in Your Portfolio Now
11:46am, Thursday, 07'th Mar 2024
Inari Medical (NARI) continues to benefit from its commitment to understanding the venous system. However, its dependency on the adoption of products is a concern.
Inari Medical, Inc. (NARI) Q4 2023 Earnings Call Transcript
09:42pm, Wednesday, 28'th Feb 2024
Inari Medical, Inc. (NARI) Q4 2023 Earnings Call Transcript
Inari Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
04:05pm, Wednesday, 14'th Feb 2024
IRVINE, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from
5 medical stocks growing earnings by triple digits
10:46am, Tuesday, 06'th Feb 2024
While most of the market focuses on hyper-growth technology stocks rewarded by Wall Street as long as they mention the word "artificial intelligence" in their earnings calls, the reality is that the
Reasons to Retain Inari Medical (NARI) in Your Portfolio Now
08:21am, Tuesday, 23'rd Jan 2024
Inari Medical (NARI) continues to benefit from its commitment to understanding the venous system. However, its dependency on the adoption of products is a concern.
Inari (NARI) Preliminary Q4 Revenues Ride on Procedure Demand
01:32pm, Friday, 12'th Jan 2024
Inari's (NARI) preliminary revenues reflect healthy procedure volume growth on the back of the rising adoption of existing and newly launched products in the United States and international markets.
Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04:01pm, Wednesday, 20'th Dec 2023
IRVINE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients
Reasons to Retain Inari Medical (NARI) in Your Portfolio Now
09:01am, Friday, 15'th Dec 2023
Inari Medical (NARI) continues to benefit from its commitment to understand the venous system. However, its dependency on the adoption of products is a concern.
Inari Medical, Inc. (NARI) Up 17.1% Since Last Earnings Report: Can It Continue?
12:52pm, Friday, 01'st Dec 2023
Inari Medical, Inc. (NARI) reported earnings 30 days ago. What's next for the stock?
Inari Medical's (NARI) PEERLESS II RCT to Boost Patient Outcome
12:49pm, Thursday, 30'th Nov 2023
Inari Medical's (NARI) latest announcement of first patient enrollment in PEERLESS II RCT is likely to aid in changing guidelines in treating intermediate-risk PE patients globally.
Reasons to Retain Inari Medical (NARI) in Your Portfolio Now
09:02am, Wednesday, 15'th Nov 2023
Inari Medical (NARI) continues to benefit from its commitment to understand the venous system. However, its dependency on the adoption of products is a concern.
